ATTENUATION OF SCH-23390-INDUCED ALTERATION OF STRIATAL DOPAMINE D1 RECEPTOR ONTOGENY BY PROLYL-LEUCYL-GLYCINAMIDE IN THE RAT

被引:7
|
作者
KOSTRZEWA, RM
SALEH, MI
机构
关键词
D O I
10.1016/0028-3908(89)90171-8
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
引用
收藏
页码:805 / 810
页数:6
相关论文
共 50 条
  • [41] STRIATAL D1 DOPAMINE RECEPTOR DENSITY FLUCTUATES DURING THE RAT ESTROUS-CYCLE
    LEVESQUE, D
    GAGNON, S
    DIPAOLO, T
    NEUROSCIENCE LETTERS, 1989, 98 (03) : 345 - 350
  • [42] IDENTIFICATION OF D1 DOPAMINE-RECEPTORS IN RAT RENAL CORTICAL HOMOGENATES USING [H-3]SCH23390
    SETH, A
    DAWSON, R
    FASEB JOURNAL, 1988, 2 (04): : A793 - A793
  • [43] EFFECTS OF ESTRADIOL ON THE ONTOGENY OF STRIATAL DOPAMINE D1 AND D2 RECEPTOR-SITES IN MALE AND FEMALE RATS
    FERRETTI, C
    BLENGIO, M
    VIGNA, I
    GHI, P
    GENAZZANI, E
    BRAIN RESEARCH, 1992, 571 (02) : 212 - 217
  • [44] Dopamine D1 receptor-induced signaling through TrkB receptors in striatal neurons
    Iwakura, Yuriko
    Nawa, Hiroyuki
    Sora, Ichiro
    Chao, Moses V.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (23) : 15799 - 15806
  • [45] SLEEP-DEPRIVATION INCREASES DOPAMINE D1 RECEPTOR ANTAGONIST [H-3] SCH 23390 BINDING AND DOPAMINE-STIMULATED ADENYLATE-CYCLASE IN THE RAT LIMBIC SYSTEM
    DEMONTIS, MG
    FADDA, P
    DEVOTO, P
    MARTELLOTTA, MC
    FRATTA, W
    NEUROSCIENCE LETTERS, 1990, 117 (1-2) : 224 - 227
  • [46] CHRONIC TREATMENT WITH SCH-23390, A SELECTIVE DOPAMINE D-1 RECEPTOR ANTAGONIST, DECREASES DOPAMINE METABOLISM IN RAT CAUDATE-NUCLEUS
    KOULU, M
    LAPPALAINEN, J
    PESONEN, U
    HIETALA, J
    SYVALAHTI, E
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 155 (03) : 313 - 316
  • [47] Dopamine D1 receptor availability in Gilles de la Tourette syndrome measured by [11C]SCH23390 PET
    Rullmann, M.
    Gkotsoulias, D.
    Schmitt, S.
    Fremer, C.
    Klages, C.
    Hartung, K.
    Bujanow, A.
    Zientek, F.
    Messerschmidt, K.
    Patt, M.
    Sabri, O.
    Mueller-Vahl, K.
    Moeller, H.
    Barthel, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S244 - S244
  • [48] The dopamine D1 receptor availability is reduced in Gilles de la Tourette syndrome: A C-11-SCH23390 PET study
    Messerschmidt, Konstantin
    Rullmann, Michael
    Gkotsoulias, Dimitrios
    Schmitt, Simon
    Fremer, Carolin
    Klages, Carolin
    Hartung, Kathrin
    Bujanow, Anna
    Zientek, Franziska
    Patt, Marianne
    Sabri, Osama
    Mueller-Vahl, Kirsten
    Moeller, Harald
    Barthel, Henryk
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [49] CHRONIC TREATMENT WITH SCH-23390 INCREASES THE PRODUCTION-RATE OF DOPAMINE-D(1) RECEPTORS IN THE NIGRO-STRIATAL SYSTEM OF THE RAT
    GIORGI, O
    PIBIRI, MG
    LOI, R
    CORDA, MG
    EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1993, 245 (02): : 139 - 145
  • [50] COMP 161-Evaluation of density functionals, semiempirical methods, SCC-DFTB and molecular mechanics force fields for prolyl-leucyl-glycinamide (PLG) analogs designed as dopamine D2 receptor modulators
    Amin, Elizabeth A.
    Wood, Richard J.
    Johnson, Rodney L.
    Young-Dixon, Breden J.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 235